Abeona Therapeutics (ABEO) Net Margin (2011 - 2026)

Abeona Therapeutics' Net Margin history runs 13 years deep, the most recent figure standing at 195.81% for Q1 2026.

• In Q1 2026, Net Margin changed N/A year-over-year to 195.81%; the TTM figure through Mar 2026 stood at 459.28% (changed N/A YoY), while the FY2025 annual figure was 1316.1%, changed N/A from the prior year.
• Net Margin for Q1 2026 stood at 195.81%, up from 651.85% in the prior quarter.
• The five-year high for Net Margin was 31086.25% in Q2 2025, with the low at 10504.41% in Q4 2022.
• The 4-year median for Net Margin is 651.85% (2025), against an average of 1313.41%.
• Peak annual rise in Net Margin reached 31207 bps in 2023, while the deepest fall reached 31207 bps in 2023.
• Abeona Therapeutics' Net Margin stood at 10504.41% in 2022, then surged by 95 bps to 475.83% in 2023, then sank by 37 bps to 651.85% in 2025, then jumped by 70 bps to 195.81% in 2026.
• Business Quant data shows ABEO's Net Margin at 195.81% in Q1 2026, 651.85% in Q4 2025, and 31086.25% in Q2 2025.